Foto del docente

Marco Rinaldo Oggioni

Professore ordinario

Dipartimento di Farmacia e Biotecnologie

Settore scientifico disciplinare: BIO/19 MICROBIOLOGIA GENERALE

Curriculum vitae

Scarica Curriculum Vitae (.docx 34KB )

Curriculum vitae di MARCO RINALDO OGGIONI, nato a Legnano (Italia) 01/01/1965, Cittadino Italiano e Tedesco. CF GGNMCR65A01E514T.

 

CONTATTO

Dipartimento di Farmacia e Biotecnologie FaBiT, Via Irnerio 42, 40126 Bologna marcorinaldo.oggioni@unibo.it 

 

POSIZIONE

2020- Professore Ordinario (BIO/19), Dipartimento di Farmacia e Biotecnologie FaBiT, Università di Bologna, Bologna, Italia (tempo definito)

2013- Chair in Microbial Genetics, Department of Genetics and Genome Biology, University of Leicester, Leicester

 

POSIZIONI PRECEDENTI

2015-21 Honorary Consultant Microbiologist, University Hospitals of Leicester NHS Trust, Leicester, UK.

2013-21 Chair in Microbial Genetics, Dept Genetics and Genome Biology, Univ. of Leicester, Leicester (tempo pieno)

1993-2013 Dirigente Medico, Azienda Ospedaliera Universitaria Senese e professore a contratto Università di Siena, Italia.

 

QUALIFICHE

2015- Fellow of the UK Higher Education Academy FHEA

1994 Specialisation Degree in Microbiology and Virology, University of Siena, Italy

1990 Medical Degree, Medical School of the University of Verona, Italy

 

FINANZIAMENTI (correnti)

IT

2024-26 GSK Contract Research 2, In vivo models for pathogen research. PI.

2024-27 EU grant MACS GAP-101131231 AMRAMR. PI

2023-25 PRIN PNRR grant P2022M8KYE. The innate immune reaction to invasive infection in human organs. PI.

2023-26 Cystic Fibrosis Foundation FFC grant FFC#13/2023. Aptides for prevention of infections. CoI.

2023-26 GSK Contract Research 1, In vivo models for pathogen research. PI.

2023-26 Ricerca Finalizzata RF-2021-12375437. RNA vaccine for S. pneumoniae and MTB. CoI.

2022-25 EU grant PNRR PE13 INF-ACT PE00000007. Emerging Infectious Diseases. CoI

2022-25 PRIN 2020 grant 202089LLEH. The CoDiCo (colonisation to disease concepts) project. PI.

2022-23 Fondazione del Monte. Migratory birds and risk of viral spillover. CoI.

UK

2022-27 BRC NIHR203327. Leicester NIHR Biomedical Research Centre. Contributor.

2022-25 BHF Project Grant PG/22/11117. Epigenetic phase variation of periodontal bacteria CoI.

2019-23 BBSRC studentship grant 2266943. The fundamental steps in the pathophysiology of meningitis. PI

 

TRIAL CLINICI:

2023-26 MOISE, CE-AVEC:668/2023/Sper/AOUBo of 19/10/2023. End date 18/10/2026. Scientific responsible.

2021-25 TIMOLD, ClinicalTrials.gov NCT05255042, REC: 21/PR/0287, IRAS 293486. End date: 31/12/2025. Chief Invest.

2018-25 TIMID, ClinicalTrials.gov NCT04620824, REC 18/EM/0057, IRAS 219992, End date: 31/12/2025. Chief Invest.

 

RESEARCH INTERESTS: Analysis of the molecular basis of mechanisms involved in the interaction of bacterial pathogens with their environment - the human host - by use of genomic tools and the study of microbial physiology. Most recent contributions were the identification of epigenetic control of bacterial gene expression and the identification of bacterial replication within a subset of tissue macrophages prior to invasive disease. Additional interests include investigation into the molecular determinants of antimicrobial drug resistance and mechanisms governing mobile genetic elements.

 

PUBLICATIONS (orcid.org/0000-0003-4117-793X)

publications: 152

h index: 57

Ultimi avvisi

Al momento non sono presenti avvisi.